Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0

Similar documents
Epworth Sleepiness Scale (ESS)

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Brief Psychiatric Rating Scale-Anchored (BPRS-A)

Hospital Anxiety and Depression Scale (HADS)

Barnes Akathisia Rating Scale (BARS)

Disability Assessment for Dementia (DAD)

Clinical Global Impression (CGI)

Neuropathic Pain Scale (NPS)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Michigan Neuropathy Screening Instrument (MNSI)

Columbia-Suicide Severity Rating Scale Baseline (C-SSRS BASELINE)

Short-Form McGill Pain Questionniare-2 (SHORT-FORM MPQ-2)

Timed Up and Go (TUG)

Pain Relief (PR) Notes to Readers

Hamilton Depression Rating Scale 17-Item (HAMD 17)

Unified Parkinson's Disease Rating Scale UPDRS

Unified Parkinson's Disease Rating Scale UPDRS

Let s Create Standard Value Level Metadata

Alzheimer s Disease-specific Therapeutic Area Supplement to the Study Data Tabulation Model User Guide

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

PharmaSUG Paper DS12

Intervention ML: Mapping of Meal data. Rahul Loharkar, inventiv Health Clinical, Pune, India Sandeep Sawant, inventiv Health Clinical, Mumbai, India

CDISC BrCa TAUG & Oncology Information Session

Project Charter. Template v2 June 3, February 25, Name of Project: Prostate Cancer (PrCa) Therapeutic Area Data Standards

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

Jerry Salyers, Accenture Accelerated R&D Services Fred Wood, Accenture Accelerated R&D Services. PhUSE 2017 Edinburgh, Scotland Paper #DS05

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DENOMINATOR: All patients undergoing anterior or apical pelvic organ prolapse (POP) surgery

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Therapeutic Area User Guide Cardiovascular V1.0 Public Review Webinar April 3, 2014

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

CFAST Asthma Project. Rhonda Facile. CDISC International Interchange Session 4B: Therapeutic Area Standards in Action November 6, 2013

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

How to manage changes to CDISC standards at Novo Nordisk. PhUSE EU Connect 2018 Sune Dandanell and Mikkel Traun

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Measure #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Quality ID #166 (NQF 0131): Coronary Artery Bypass Graft (CABG): Stroke- National Quality Strategy Domain: Effective Clinical Care

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

Quality ID #110 (NQF 0041): Preventive Care and Screening: Influenza Immunization National Quality Strategy Domain: Community/Population Health

Quality ID #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority

DESCRIPTION: Percentage of patients with dementia for whom an assessment of functional status was performed at least once in the last 12 months

Quality ID #117 (NQF 0055): Diabetes: Eye Exam National Quality Strategy Domain: Effective Clinical Care

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

Measure #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

Quality ID #154 (NQF: 0101): Falls: Risk Assessment National Quality Strategy Domain: Patient Safety

Examples: Tables. Descriptive stats with ANOVA, ANCOVA, and t test p values Frequency and percent Correlation coefficients

DENOMINATOR: All female patients aged 65 years and older with a visit during the measurement period

Quality ID #225 (NQF 0509): Radiology: Reminder System for Screening Mammograms National Quality Strategy Domain: Communication and Care Coordination

Measure #282: Dementia: Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Measure #286: Dementia: Counseling Regarding Safety Concerns National Quality Strategy Domain: Patient Safety

Measure #412: Documentation of Signed Opioid Treatment Agreement National Quality Strategy Domain: Effective Clinical Care

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

DESCRIPTION: Percentage of final reports for screening mammograms that are classified as probably benign

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Patient Reported Outcome High Priority

2018 CMS Web Interface

Measure Reporting via Registry: CPT only copyright 2015 American Medical Association. All rights reserved. 11/17/2015 Page 1 of 9

Robin Feldman, MBA & Joy Esterlitz, MS NINDS CDE Team The Emmes Corporation Rockville, MD USA. Thursday, September 14, 2017

PharmaSUG Paper DS04

2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

DENOMINATOR: All patient visits for patients aged 21 years and older with a diagnosis of OA

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

DENOMINATOR: All female patients aged 65 years and older with a diagnosis of urinary incontinence

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

Quality ID #278: Sleep Apnea: Positive Airway Pressure Therapy Prescribed National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients aged 18 years and older seen for at least two visits or at least one preventive visit during the measurement period

Quality ID #406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

2019 CMS Web Interface

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process

Quality ID# 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients National Quality Strategy Domain: Effective Clinical Care

2018 CMS Web Interface

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Quality ID #155 (NQF: 0101): Falls: Plan of Care National Quality Strategy Domain: Communication and Care Coordination

Measure #117 (NQF 0055): Diabetes: Eye Exam National Quality Strategy Domain: Effective Clinical Care

DENOMINATOR: All patients 18 and older prescribed opiates for longer than six weeks duration

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

Critical Path Institute Coalition Against Major Diseases (CAMD) Alzheimer s Clinical Trial Database

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

DENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis

Quality ID #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

Denominator Criteria (Eligible Cases): Patient encounter during the performance period (CPT): 78300, 78305, 78306, 78315, 78320

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Quality ID #178: Rheumatoid Arthritis (RA): Functional Status Assessment National Quality Strategy Domain: Effective Clinical Care

Measure #389: Cataract Surgery: Difference Between Planned and Final Refraction - National Quality Strategy Domain: Effective Clinical Care

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2018 CMS Web Interface

Measure #265: Biopsy Follow-Up National Quality Strategy Domain: Communication and Care Coordination

2018 CMS Web Interface

Transcription:

Modified Hachinski Ischemic Scale: NACC Version (MHIS-NACC) v.1.0 Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CAMD AD v2.0 Team and the CDISC Questionnaire Sub-team Notes to Readers This supplement is intended to be used with other CDISC User Guides for specific Therapeutic/Disease Areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical trials. Revision History Date Version Summary of Changes 2013-08-29 0.1 Modified Hachinski Ischemic Scale-NACC Version (MHIS-NACC)- Draft 2013-09-18 1.0 Modified Hachinski Ischemic Scale--NACC Version (MHIS-NACC) 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 1

Introduction This document describes the CDISC implementation of the Modified Hachinski Ischemic Scale- NACC Version (MHIS-NACC) questionnaire, a standard questionnaire that is typically used in clinical trials as an assessment of functional disability used by clinicians. The information is gathered from information obtained from history/physical/neurological exams and/or medical records. The MHIS-NACC questionnaire preceded the CDISC CDASH CRF standards and based on its public domain status cannot be modified to CDASH standards. The representation of data collected for this questionnaire is based on the Study Data Tabulation Model Implementation Guide (SDTMIG) QS domain model, which can be found at the CDISC website at: (http://www.cdisc.org/sdtm). These specific implementation details for this questionnaire are meant to be used in conjunction with the SDTMIG. All questionnaire documentation can be found on the CDISC web site at: (http://www.cdisc.org/content2909). The CDISC Intellectual Property Policy can be found on the CDISC web site at: (http://www.cdisc.org/bylaws-and-policies). Representations and Warranties, Limitations of Liability, and Disclaimers This document is a supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material. Copyright Status This instrument is copyright approved. CDISC has included the Modified Hachinski Ischemic Scale-NACC Version (MHIS-NACC) as part of CDISC Data Standards. Hence, CDISC developed QSTESTCD and QSTEST for each question based on the actual question text on the questionnaire. There may be many versions of this questionnaire in the public domain or copyright questionnaire. CDISC has chosen to use this version as the data standard. The CDISC documentation of this instrument consists of: (1) controlled terminology, (2) standard database structure with examples, and (3) case report forms annotated with the CDISC SDTMIG submission values. Note: CDISC controlled terminology is maintained by NCI EVS. The most recent version should be accessed through the CDISC website. (http://www.cdisc.org/terminology) CDISC has developed this documentation at no cost to copyright holder or any additional cost to users of the instrument beyond the normal licenses fees charged by the copyright holder. 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 2

CDISC acknowledges John Wiley & Sons (Rosen Modification of Hachinski Ischemic Score (Ann Neurol7:486-488, 1980). Copyright John Wiley & Sons, Inc. Reproduced by permission.) for the agreement to include the Modified Hachinski Ischemic Scale (MHIS) in the CDISC data standards. (Reproduced with permission. Copyright 2011 University of Washington. Created and published by the ADC Clinical Task Force (John C. Morris, MD, Chair) and the National Alzheimer's Coordinating Center (Walter A. Kukull, PhD, Director). This publication was funded by the National Institutes of Health through the National Institute on Aging (Cooperative Agreement U01 AG016976). 3. The QS Domain Model 3.1 Assumptions for Questionnaire Domain Model All assumptions and business rules described in the SDTMIG QS domain are applicable to this supplement. Additional assumptions specific to the Modified Hachinski Ischemic Scale-NACC Version (MHIS-NACC) questionnaire are listed below. Modified Hachinski Ischemic Scale-NACC Version (MHIS-NACC) is a scale that clinicians may use to provide an assessment of cognitive function and physical disability. It consists of 8 items answered PRESENT or ABSENT. The information is gathered from medical history, physical exam, neurological exams and other medical records. 1. The total score is included as a field on this version of the CRF, therefore CDISC controlled terminology has been created for it. 2. The questionnaire evaluator should be stored in QSEVAL. For MHIS-NACC, the evaluator is usually defined as INVESTIGATOR. Additional identifying information to further distinguish the rater in QSEVAL should be stored in QSEVALID. An example is rater initials. 3. Terminology: a. QSCAT, QSTESTCD and QSTEST are approved CDISC controlled terminology. b. A full list of value sets for qualifier, timing, result and unit fields is provided in Section 4: SDTM Mapping Strategy. 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3

CDISC SDTM MHIS Questionnaire Supplement (Version 1.0) Example for the Modified Hachinski Ischemic Scale-NACC Version (MHIS-NACC)) QS Domain Model The MHIS-NACC example below shows the terminology used to implement the questionnaire in the QS domain. This example shows the data for one subject collected at the baseline visit for a (MHIS-NACC) questionnaire. The example uses CDISC controlled terminology for QSTESTCD, QSTEST, and QSCAT. All original results are represented with preferred terminology in QSORRES. This result is then transformed into a standard numeric score in QSSTRESN and a character representation of the standard numeric score in QSSTRESC. Rows 1-8: Represent the questions from the MHIS-NACC CRF. Row 9: The Total Score is recorded on the CRF. qs.xpt Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSSTRESC 1 STUDYX QS P0001 1 MHIS0101 MHIS01-Abrupt Onset MHIS-NACC PRESENT 2 2 STUDYX QS P0001 2 MHIS0102 MHIS01-Stepwise Deterioration MHIS-NACC PRESENT 1 3 STUDYX QS P0001 3 MHIS0103 MHIS01-Somatic Complaints MHIS-NACC ABSENT 0 4 STUDYX QS P0001 4 MHIS0104 MHIS01-Emotional Incontinence MHIS-NACC PRESENT 1 5 STUDYX QS P0001 5 MHIS0105 MHIS01-History/Presence of Hypertension MHIS-NACC PRESENT 1 6 STUDYX QS P0001 6 MHIS0106 MHIS01-History of Stroke MHIS-NACC PRESENT 2 7 STUDYX QS P0001 7 MHIS0107 MHIS01-Focal Neurological Symptoms MHIS-NACC ABSENT 0 8 STUDYX QS P0001 8 MHIS0108 MHIS01-Focal Neurological Signs MHIS-NACC ABSENT 0 9 STUDYX QS P0001 9 MHIS0109 MHIS01-Total Score MHIS-NACC 7 7 qs.xpt cont. Row QSSTRESN QSBLFL QSEVAL QSEVALID VISITNUM QSDTC 1 (cont) 2 Y INVESTIGATOR BS 1 2012-11-16 2 (cont) 1 Y INVESTIGATOR BS 1 2012-11-16 3 (cont) 0 Y INVESTIGATOR BS 1 2012-11-16 4 (cont) 1 Y INVESTIGATOR BS 1 2012-11-16 5 (cont) 1 Y INVESTIGATOR BS 1 2012-11-16 6 (cont) 3 Y INVESTIGATOR BS 1 2012-11-16 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 4

Row QSSTRESN QSBLFL QSEVAL QSEVALID VISITNUM QSDTC 7 (cont) 0 Y INVESTIGATOR BS 1 2012-11-16 8 (cont) 0 Y INVESTIGATOR BS 1 2012-11-16 9 (cont) 7 Y INVESTIGATOR BS 1 2012-11-16 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 5

Section 4: SDTM Mapping Strategy MHIS-NACC specific mapping strategy: This section is used for reference with the annotated CRF for further details on the CRF data capture and to understand the alignment of the questionnaire to the SDTM QS domain. It also provides guidance on how the result variables (QSORRES, QSSTRESC, and QSSTRESN) should be populated for the questionnaire. For all questions, the following scale should be used. QSTESTCD=MHIS0102 QSTEST = MHIS01-Stepwise Deterioration QSTESTCD=MHIS0103 QSTEST = MHIS01-Somatic Complaints QSTESTCD=MHIS0104 QSTEST = MHIS01-Emotional Incontinence QSTESTCD=MHIS0105 QSTEST = MHIS01-History/Presence of Hypertension QSORRES QSSTRESC QSSTRESN PRESENT 1 1 ABSENT 0 0 QSTESTCD=MHIS0101 QSTEST = MHIS01-Abrupt Onset QSTESTCD=MHIS0106 QSTEST = MHIS01-History of Stroke QSTESTCD=MHIS0107 QSTEST = MHIS01-Focal Neurological Symptoms QSTESTCD=MHIS0108 QSTEST = MHIS01-Focal Neurological Signs QSORRES QSSTRESC QSSTRESN PRESENT 2 2 ABSENT 0 0 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 6

End of Document 2013 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 7